Literature DB >> 23838226

Discontinuation of reflex testing of stool samples for vancomycin-resistant enterococci resulted in increased prevalence.

Mandy Bodily1, Kathleen M McMullen, Anthony J Russo, Nupur D Kittur, Joan Hoppe-Bauer, David K Warren.   

Abstract

Discontinuation of reflex testing of stool submitted for Clostridium difficile testing for vancomycin-resistant enterococci (VRE) led to an increase in the number of patients with healthcare-associated VRE bacteremia and bacteriuria (0.21 vs 0.36 cases per 1,000 patient-days; P<.01). Cost-benefit analysis showed reflex screening and isolation of VRE reduced hospital costs.

Entities:  

Mesh：

Year:  2013        PMID： 23838226      PMCID： PMC4689131          DOI： 10.1086/671276

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN： 0899-823X            Impact factor:   3.254


  11 in total

Review 1.  Systematic review of measurement and adjustment for colonization pressure in studies of methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, and clostridium difficile acquisition.

Authors:  Adebola O Ajao; Anthony D Harris; Mary-Claire Roghmann; J Kristie Johnson; Min Zhan; Jessina C McGregor; Jon P Furuno
Journal:  Infect Control Hosp Epidemiol       Date:  2011-05       Impact factor: 3.254

2.  Undetected vancomycin-resistant Enterococcus stool colonization in a Veterans Affairs Hospital using a Clostridium difficile-focused surveillance strategy.

Authors:  Amy J Ray; Claudia K Hoyen; Sarbani M Das; Elizabeth C Eckstein; Curtis J Donskey
Journal:  Infect Control Hosp Epidemiol       Date:  2002-08       Impact factor: 3.254

Review 3.  SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus.

Authors:  Carlene A Muto; John A Jernigan; Belinda E Ostrowsky; Hervé M Richet; William R Jarvis; John M Boyce; Barry M Farr
Journal:  Infect Control Hosp Epidemiol       Date:  2003-05       Impact factor: 3.254

4.  Multihospital surveillance of nosocomial methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococcus, and Clostridium difficile: analysis of a 4-year data-sharing project, 1999-2002.

Authors:  Terry Burger; Deborah Fry; Renee Fusco; Maureen Luschini; Joan Bradley Mayo; Vivien Ng; Kathleen Roye-Horn; Nancy Wagner
Journal:  Am J Infect Control       Date:  2006-09       Impact factor: 2.918

5.  2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings.

Authors:  Jane D Siegel; Emily Rhinehart; Marguerite Jackson; Linda Chiarello
Journal:  Am J Infect Control       Date:  2007-12       Impact factor: 2.918

6.  Increasing incidence of linezolid-intermediate or -resistant, vancomycin-resistant Enterococcus faecium strains parallels increasing linezolid consumption.

Authors:  Marc H Scheetz; Stephanie A Knechtel; Michael Malczynski; Michael J Postelnick; Chao Qi
Journal:  Antimicrob Agents Chemother       Date:  2008-04-07       Impact factor: 5.191

7.  Enteric carriage of vancomycin-resistant Enterococcus faecium in patients tested for Clostridium difficile.

Authors:  J M Garbutt; B Littenberg; B A Evanoff; D Sahm; L M Mundy
Journal:  Infect Control Hosp Epidemiol       Date:  1999-10       Impact factor: 3.254

8.  Rapid control of an outbreak of vancomycin-resistant enterococci in a French university hospital.

Authors:  J-C Lucet; L Armand-Lefevre; J-J Laurichesse; A Macrez; E Papy; R Ruimy; C Deblangy; A Lozach; I Lolom; V Jarlier; A Andremont; C Leport
Journal:  J Hosp Infect       Date:  2007-08-23       Impact factor: 3.926

9.  Attributable costs of enterococcal bloodstream infections in a nonsurgical hospital cohort.

Authors:  Anne M Butler; Margaret A Olsen; Liana R Merz; Rebecca M Guth; Keith F Woeltje; Bernard C Camins; Victoria J Fraser
Journal:  Infect Control Hosp Epidemiol       Date:  2010-01       Impact factor: 3.254

10.  Control of endemic vancomycin-resistant Enterococcus among inpatients at a university hospital.

Authors:  David P Calfee; Eve T Giannetta; Lisa J Durbin; Teresa P Germanson; Barry M Farr
Journal:  Clin Infect Dis       Date:  2003-07-14       Impact factor: 9.079
View more
  3 in total

Review 1.  Resistance Mechanisms, Epidemiology, and Approaches to Screening for Vancomycin-Resistant Enterococcus in the Health Care Setting.

Authors:  Matthew L Faron; Nathan A Ledeboer; Blake W Buchan
Journal:  J Clin Microbiol       Date:  2016-05-04       Impact factor: 5.948

2.  Reinstatement of Reflex Testing of Stool Samples for Vancomycin-Resistant Enterococci (VRE) Resulted in Decreased Incidence of Hospital-Associated VRE.

Authors:  Satish Munigala; Kathleen M McMullen; Anthony J Russo; S Reza Jafarzadeh; Joan Hoppe-Bauer; Carey-Ann D Burnham; David K Warren
Journal:  Infect Control Hosp Epidemiol       Date:  2017-02-21       Impact factor: 3.254

3.  Vancomycin-resistant enterococci (VRE) screening and isolation in the general medicine ward: a cost-effectiveness analysis.

Authors:  Stephen Mac; Tiffany Fitzpatrick; Jennie Johnstone; Beate Sander
Journal:  Antimicrob Resist Infect Control       Date:  2019-10-29       Impact factor: 4.887
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.